✦ LIBER ✦

Cost-Effectiveness Analysis of Etanercept in the Treatment of Rheumatoid Arthritis in Institutional Market in Ecuador

✍ Scribed by Albuja, M.F.; Torres, F.G.; Mould, J.; Estévez, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS22 COST-EFFECTIVENESS ANALYSIS OF ETA

✍ J. Vargas-Valencia; M. Sotelo-Guzmán; J.F. Mould-Quevedo; E. Muciño-Ortega; R.M. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PMS14 Cost-Effectiveness Analysis of Eta

✍ Zhang, Y.; Yang, L.; Dong, P.; Xie, X.; Tang, B. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

Cost-effectiveness analysis of rituximab

✍ Sonja Merkesdal; Timm Kirchhoff; Diane Wolka; Gunter Ladinek; Adrian Kielhorn; A 📂 Article 📅 2009 🏛 Springer 🌐 French ⚖ 293 KB

PMS49 Cost-Effectiveness Analysis of Eta

✍ P. Guijarro; C. Crespo; M. Brosa 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PAR1 COST-EFFECTIVENESS ANALYSIS OF ETAN

✍ MG Saggia; FP Pina 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Cost-effectiveness analysis of biologica

✍ Torres Toala, F.G.; Albuja Riofrio, M.F.; Mould Quevedo, J.F.; Estévez, C. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB